Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer.

导出 OA

翻译打印收藏纠错

作者： Fahd,Al-Mulla ^[1] ; Milad S,Bitar ; Jean Paul,Thiery ; Tan Tuan,Zea ; Devasis,Chatterjee ; Lindsay,Bennett ; Sungdae,Park ; Joanne,Edwards ; Kam C,Yeung

作者单位： Department of Pathology, Molecular Pathology Unit, Faculty of Medicine, Kuwait University, Health Sciences Centre Safat, Kuwait. ^[1]

关键词 ERBB2 ERK Luminal PEBP1 RKIP aggressive cancer basal breast cancer claudin-low disease-free survival estrogen receptor prognosis

PMID 24224123

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览58

American journal of cancer research

2013年3卷5期

446-64页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer.

American journal of cancer research

相似文献

American journal of cancer research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Clinical implications for loss or diminution of expression of Raf-1 kinase inhibitory protein and its phosphorylated form in ductal breast cancer.

American journal of cancer research

相似文献

American journal of cancer research

相关期刊

检索历史清除